 | Heron Therapeutics, Inc. | |||
| NCM : HRTX || Location: United States | ||||
$2.64-0.07 (-2.58%) |
2.31 M | 2.51 - 2.74 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 25.552 M |
| March 15, 2024 | 25.426 M |
| Feb. 29, 2024 | 24.533 M |
| Feb. 15, 2024 | 24.616 M |
| Jan. 31, 2024 | 24.326 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.17 | -0.07 | 58.06% |
| 09/30/2023 | -0.30 | -0.17 | 43.03% |
| 06/30/2023 | -0.24 | -0.35 | -47.00% |
| 03/31/2023 | -0.21 | -0.27 | -30.37% |
| 12/31/2022 | -0.29 | -0.17 | 41.52% |
HRTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 150.329M | Shares Float | 122.025M |
| Short Float | 25.552M | Market Cap | 396.87M |
| Institution ownership | 76.01% | Insider ownership | 0.931% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.80 | Forward EPS | -0.36 |